Maha Hussain, MD, FACP
Professor of Medicine & Urology, University of Michigan Comprehensive Cancer Center
Dr Hussain is the author of more than 175 scholarly articles and book chapters and has been an invited speaker at meetings around the world. She serves/has served on the editorial boards for several national and international specialty publications, including the Journal of Clinical Oncology and Clinical Genitourinary Cancer. Her research efforts are focused on the development of novel therapeutics integrating scientific advances into clinical trials for prostate and bladder cancer.
Dr Hussain is the recipient of several honors and awards including the American Society of Clinical Oncology Statesman Award, the University of Michigan Medical School League of Research Excellence and the 2012 Clinical & Health Services Research award.
Dr Hussain has served as a member of the NCI-Cancer Biomarker Study Section and the NCI’s Prostate cancer task force. She is an FDA consultant and has served as a member and the Chair for the FDA Oncology Drug Advisory Committee (ODAC), chair of the Education Committee of the American Society of Clinical Oncology (ASCO), Chair for 2011 ASCO Genitourinary Cancer Symposium Program Committee and a member of the 2012 and 2013 ASCO-GU Symposium Steering Committee in addition to other institutional, regional and national service and leadership roles.